Calendar

Upcoming Events
September 14-15, 2018
MAP 2018 – Molecular Analysis for Personalised Therapy


MAP 2018 – Molecular Analysis for Personalised Therapy is a one-of-a-kind meeting designed by a faculty of highly influential key opinion leaders. A truly unique programme will feature speakers with the highest publication track record in the field. 

MAP 2018: 
  • Will be the place to network with the leading academic representatives working in personalised medicine for cancer patients.
  • Is a joint initiative of Cancer Research UK, UNICANCER and ESMO and aims to provide oncologists with expert guidance on interpreting genomic alterations to design tailored treatment programmes for their patients.
  • Is highly recommended for medical oncologists, young professionals, academics, regulators, industry R&D representatives and investigators and all those interested in discussing the clinical interpretation of molecular tests with a view to providing effective cancer treatment.

    We look forward to see you in Paris in 2018!
September 20-24, 2018
September 23, 2018
barcelona

The 5th ESU Masterclass on Lasers in Urology (esulasers18) is organized by European School of Urology (ESU), EAU Section of Uro-Technology (ESUT) and will be held during Nov 22 - 23, 2018 at Barcelona, Catalonia, Spain.
October 4, 2018
Screen Shot 2018 07 12 at 2.20.41 PM

The World Uro Oncology Federation was formed in May 2005 by the leadership of the 19 societies of Urologic Oncology from around the world met to form the World Uro Oncology Federation (WUOF). These societies, represent very diverse regions, traditions, health care systems, cultures and ethnicities. There was a common sense amongst the leaders that many of the challenges they faced were similar, and that they had much to learn from each other. The individual societies share a number of common goals, related to education and training, research, scope of practice, and collegiality. The purpose of the WUOF was to provide a formal liason between these groups.
October 4-7, 2018
Screen Shot 2018 07 12 at 2.30.26 PM

The World Uro Oncology Federation was formed in May 2005 by the leadership of the 19 societies of Urologic Oncology from around the world met to form the World Uro Oncology Federation (WUOF). These societies, represent very diverse regions, traditions, health care systems, cultures and ethnicities. There was a common sense amongst the leaders that many of the challenges they faced were similar, and that they had much to learn from each other. The individual societies share a number of common goals, related to education and training, research, scope of practice, and collegiality. The purpose of the WUOF was to provide a formal liason between these groups.
October 4-5, 2018
Screen Shot 2018 07 12 at 3.00.24 PM

Dear friends, colleagues!

The Annual Congress of the Russian Society of Oncourologists crossed the ten-year boundary. And I am glad to welcome you again at one of the largest scientific and practical events of the country - at the XIII Congress of the Russian University.

Progress in oncology - new technologies, molecules, medicines, new indications for the use of existing ones - requires constant improvement from us, constant analysis of scientific achievements and their impact on the main indicators - the duration and quality of life of patients.

From the very beginning of its existence, the RPOU actively promoted the idea of ​​consolidating physicians of different specialties, developing a multidisciplinary approach to the treatment of malignant formations of the genitourinary system. I sincerely hope that the living dialogue of clinicians and pathomorphologists will not be limited to the framework of the congress.

Annually in the framework of the Congress there is a session of young scientists, the most creative and promising specialists of our professional community. Here you can hear about the newest and most advanced achievements and meet new leaders in oncourology.

Let this congress be rich, interesting, and give a new impetus to our joint work.

With best wishes,
President of the Russian Society of Oncourologists,
Corresponding Member of the Russian Academy of Sciences, Professor
V.B. Matveyev